Prediction of Pathological Stage in Patients with Clinical Stage T1c Prostate Cancer: The New Challenge
- 1 July 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Standardization, analytical validation, and quality control of intermediate endpoint biomarkersUrology, 2001
- Analysis of repeated biopsy results within 1 year after a noncancer diagnosisUrology, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, 1999
- Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomyUrology, 1999
- Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1999
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Prostate Cancer Incidence and Mortality Rates among White and Black MenEpidemiology, 1997
- Molecular and cellular biology of prostate cancerCancer and Metastasis Reviews, 1997